ISCG: Soft Quality, Elevated Volatility, Sluggish Performance [Seeking Alpha]
Inhibrx Biosciences, Inc. (INBX)
Company Research
Source: Seeking Alpha
Vasily Zyryanov 2.06K Follower s Follow Summary ISCG is a passively managed investment vehicle focused on small-cap stocks with appealing growth characteristics. Since the index change in 2021, ISCG's results have been lackluster as it has underperformed small-cap peers and the market has proxied with IVV. Neither its growth nor its value and quality characteristics are appealing enough. In the absence of a strong downside catalyst, I am leaning towards a Hold rating. Juntaski/iStock via Getty Images With the market now at the crossroads again, a question worth asking is whether a rotation from tech bellwethers towards less crowded corners of the equity universe makes sense. A hypothesis might be constructed here that, as bellwethers have been climbing higher too fast, their smaller, underfollowed counterparts have not been given deserved attention, and thus countless mispriced opportunities have emerged. And one of the most obvious ways to play that is to foray int
Show less
Read more
Impact Snapshot
Event Time:
INBX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INBX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INBX alerts
High impacting Inhibrx Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
INBX
News
- Inhibrx: The Biotech Spinoff Poised For Big Gains [Forbes]Forbes
- Inhibrx gains after insider purchases from CEO [Seeking Alpha]Seeking Alpha
- Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]Yahoo! Finance
- Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsPR Newswire
- Inhibrx, Inc. (NASDAQ: INBX) is now covered by analysts at JMP Securities. They set a "market perform" rating on the stock.MarketBeat
INBX
Earnings
- 2/28/24 - Miss
INBX
Sec Filings
- 9/16/24 - Form 4
- 9/12/24 - Form 4
- 9/10/24 - Form 4
- INBX's page on the SEC website